Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: ' A Journey To Focus On Data And Digital '

“We ' re in a journey to focus Novartis as a medicines company powered by data and digital, ” chief executive Vas Narasimhan said on a conference call explaining the deal to analysts. “And already this year, we ' re off to a strong start to realize that goal. ”
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:NVS NASDAQ:AVXS NASDAQ:SRPT Source Type: news